These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31527073)

  • 1. How I treat Waldenström macroglobulinemia.
    Dimopoulos MA; Kastritis E
    Blood; 2019 Dec; 134(23):2022-2035. PubMed ID: 31527073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Chakraborty R; Kapoor P; Ansell SM; Gertz MA
    Expert Rev Anticancer Ther; 2015; 15(10):1143-56. PubMed ID: 26196236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
    Jalali S; Ansell SM
    Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of genomics in Waldenström macroglobulinemia.
    Branagan AR; Lei M; Treon SP; Castillo JJ
    Leuk Lymphoma; 2021 Aug; 62(8):1805-1815. PubMed ID: 33569985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current approach to Waldenström Macroglobulinemia.
    Ravi G; Kapoor P
    Cancer Treat Res Commun; 2022; 31():100527. PubMed ID: 35149375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
    Fang H; Kapoor P; Gonsalves WI; Frederick LA; Viswanatha D; Howard MT; He R; Morice WG; McPhail ED; Greipp PT; Ansell SM; Kyle RA; Gertz MA; Paludo J; Abeykoon J; King RL
    Am J Clin Pathol; 2018 Jul; 150(2):168-176. PubMed ID: 29868855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Waldenström macroglobulinemia in 2020.
    Castillo JJ; Treon SP
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):372-379. PubMed ID: 33275726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.
    Thomas SK
    Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):347-355. PubMed ID: 34980578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.
    Castillo JJ; Hunter ZR; Yang G; Treon SP
    Expert Rev Hematol; 2017 Aug; 10(8):739-744. PubMed ID: 28617062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bing-Neel syndrome: Two unexpected cases and a review of the literature.
    Van Cauwenberge MG; Depreter B; Dumoulin EN; Emmerechts J; Nollet F; Vanopdenbosch LJ
    J Neurol Sci; 2015 Sep; 356(1-2):19-26. PubMed ID: 26159625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is new in the treatment of Waldenstrom macroglobulinemia?
    Castillo JJ; Treon SP
    Leukemia; 2019 Nov; 33(11):2555-2562. PubMed ID: 31591468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approach to Waldenström macroglobulinemia.
    Kapoor P; Rajkumar SV
    Blood Rev; 2023 Nov; 62():101129. PubMed ID: 37659912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenström macroglobulinemia treatment algorithm 2018.
    Gertz MA
    Blood Cancer J; 2018 May; 8(4):40. PubMed ID: 29712895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waldenström macroglobulinemia: from biology to treatment.
    Sahin I; Leblebjian H; Treon SP; Ghobrial IM
    Expert Rev Hematol; 2014 Feb; 7(1):157-68. PubMed ID: 24405328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I treat Waldenström macroglobulinemia.
    Treon SP
    Blood; 2015 Aug; 126(6):721-32. PubMed ID: 26002963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive
    Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
    Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management.
    Gertz MA
    Am J Hematol; 2023 Feb; 98(2):348-358. PubMed ID: 36588395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Waldenström's macroglobulinemia].
    Watanabe R
    Rinsho Ketsueki; 2015 Oct; 56(10):2074-85. PubMed ID: 26458447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management.
    Gertz MA
    Am J Hematol; 2021 Feb; 96(2):258-269. PubMed ID: 33368476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Emerging Treatments for Waldenström Macroglobulinemia.
    Grimont CN; Castillo Almeida NE; Gertz MA
    Acta Haematol; 2021; 144(2):146-157. PubMed ID: 32810857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.